Patients with schizophrenia who are enrolled in the Phase 3 Recover trial report improved symptoms while maintaining safety.

More People Have Therapists Than Ever Before, and That's a Good Thing

Young people are leading the charge to destigmatize therapy

Case Report: When 'Earworm' Becomes Musical Obsession

SSRI treatment gives some successes for OCD-related "stuck song syndrome" accompanied by anxiety

Measuring Tardive Dyskinesia Symptoms With the AIMS

AIMS exams should be routine, even when using telemedicine, experts say

Psychiatric Risk Transmission; Phase III Win, Flop for Anxiety; 10K Hotel Overdoses

News and commentary from the psychiatry world

Greater Willingness to Seek Help May Drive Rise in Mental Health Visits

Changes in physician coding habits could also be playing a role

Integrated HIV Prevention: Bridging Mental Health Care and Sexual Wellness

Integrated HIV Prevention: Bridging Mental Health Care and Sexual Wellness

HIV Prevention and Mental Health: A Person-Centered Approach to PrEP

HIV Prevention and Mental Health: A Person-Centered Approach to PrEP

Clinical Connections in HIV Prevention: Integrating PrEP Into Mental Health Settings

Clinical Connections in HIV Prevention: Integrating PrEP Into Mental Health Settings

APA: American Psychiatric Association

Psychedelic Retreats, a Booming Business With Few Safety Guardrails

Many carry "potential for physical, psychological, and interpersonal harms," researchers say

Psych Congress: Psychiatry & Behavioral Health Learning Network

Suicide With Food Preservative; Xanax Recall; 19% of America Depressed

News and commentary from the psychiatry world

Novel Antipsychotic Shows Promise in Acute Schizophrenia

Downsides with current options leave a large unmet need for new therapies, researcher says

No Need to Break the Goldwater Rule. Here's What Docs Propose Instead.

There's a difference between diagnosis from afar, and raising clinically informed concerns

Trump Administration to Revive Axed 988 Line for LGBTQ+ Youth in Crisis

An act of Congress forced the administration to reverse course

FDA Plans Ultra-Fast Review of Three Psychedelics for Depression, PTSD

Recent moves on psychedelics reflect growing support for the substances among Trump's supporters